Surmodics Revenue and Competitors
Estimated Revenue & Valuation
- Surmodics's estimated annual revenue is currently $105.1M per year.
- Surmodics received $25.0M in venture funding in March 2009.
- Surmodics's estimated revenue per employee is $340,259
- Surmodics's current valuation is $657.7M. (January 2022)
Employee Data
- Surmodics has 309 Employees.
- Surmodics grew their employee count by -3% last year.
Surmodics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP & General Manager - Medical Device Business Unit | Reveal Email/Phone |
2 | VP Research & Development | Reveal Email/Phone |
3 | VP and Corporate Controller | Reveal Email/Phone |
4 | VP Finance and Chief Financial Officer | Reveal Email/Phone |
5 | Senior Director Operations | Reveal Email/Phone |
6 | Sr. Director, Education and Organizational Development - Vascular Interventions | Reveal Email/Phone |
7 | Senior Director, Clinical Affairs | Reveal Email/Phone |
8 | Director, Business Development | Reveal Email/Phone |
9 | Associate General Counsel, Sr. Director | Reveal Email/Phone |
10 | Chief Operating Officer Medical Devices | Reveal Email/Phone |
Surmodics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $30.6M | 122 | 4% | N/A | N/A |
#2 | $18.6M | 74 | 35% | N/A | N/A |
#3 | $75.6M | 301 | 20% | N/A | N/A |
#4 | $12M | 48 | 4% | N/A | N/A |
#5 | $2.8M | 11 | 10% | N/A | N/A |
#6 | $3M | 12 | 0% | N/A | N/A |
#7 | $24.6M | 98 | 5% | N/A | N/A |
#8 | $11.5M | 46 | 21% | N/A | N/A |
#9 | $7.3M | 29 | 4% | N/A | N/A |
#10 | $13.8M | 55 | -10% | N/A | N/A |
What Is Surmodics?
Surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. Following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. Throughout its transformation, Surmodics mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals
N/A
Total Funding
309
Number of Employees
$105.1M
Revenue (est)
-3%
Employee Growth %
$657.7M
Valuation
N/A
Accelerator
Surmodics News
Barclays PLC increased its holdings in shares of Surmodics by 40.1% in the fourth quarter. Barclays PLC now owns 19,159 shares of the company's...
will host a conference call at 08:30 AM ET on April 27, 2022, to discuss Q2 2022 earnings results. How to Attend Surmodics (SRDX) Conference...
SurModics, Sono-Tek, Royal DSM, Hydromer, Biocoat, Specialty Coating Systems, Covalon Technologies, Bayer, PPG Industries, Harland Medical...
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2021 third quarter ended June 30, 2021 and updated its financial outlook for its fiscal 2021. Summary of Third Quarter and ...
SurModics, Inc. (Nasdaq: SRDX), an Eden Prairie, Minnesota-based provider of medical device and in vitro diagnostic technologies, acquired Creagh Medical Ltd., a Ballinasloe, Ireland-based developer and manufacturer of percutaneous transluminal angioplasty (PTA) balloon catheters, for €30m (appr ...
Other Companies in Eden Prairie
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $57.8M | 319 | -8% | N/A |
#2 | $118.5M | 327 | 6% | N/A |
#3 | $68.1M | 339 | 17% | N/A |
#4 | $63.3M | 344 | -21% | $26M |
#5 | $107.2M | 350 | 41% | N/A |
Surmodics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2009-03-05 | $25.0M | Undisclosed | Wells Fargo Bank NA | Article |